ArticleFrontiers in immunology2026

Cadonilimab alone as neoadjuvant immunotherapy followed by radical resection for dMMR/MSI-H gastric adenocarcinoma: a case report.

Keqin Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.